S738 Real World Evidence Comparing Vedolizumab and Ustekinumab in Anti-TNF Experienced Patients With Crohn’s Disease
Kappelman M, Adimadhyam S, Hou L, Simon A, Dobes A, Parlett L, Haynes K, Selvan M, Ma Q, Nair V, Burris J, Dorand J, Long M. S738 Real World Evidence Comparing Vedolizumab and Ustekinumab in Anti-TNF Experienced Patients With Crohn’s Disease. The American Journal Of Gastroenterology 2022, 117: e519-e520. DOI: 10.14309/01.ajg.0000859592.38187.d3.Peer-Reviewed Original Research